glutathione dave asprey Podcast Episodes Featuring BodyBio Dave Asprey Thinks Coffee Is
Description
Clinical trials show tirzepatide produces 22.5% average weight loss compared to semaglutides 14.9%, likely because activating both incretin pathways provides more comprehensive metabolic regulation than activating one pathway alone
Think of it like filling a bathtub with the drain partially open
Others receive it as a quick stand-alone infusion
This temporary nature actually adds to its safety profile, as it means any unwanted effects aren't permanent
In their paper, Zielinska et al
